Therapeutic gene editing and multimodal imaging in juvenile macular degeneration

Ended Project Grant Awarded Last action

Award ID
R24EY028758
Recipient
Awarding agency
Obligated
$21,848,123

Award facts

Assistance listing
93.867 Vision Research
Completion date
Originally
Funding
  • $17,468,889.00 Federal
  • $4,379,234.00 Non-federal
Place of performance
New York, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $2,153,230 $0
Amendment $0 $0
Amendment $0 $0
Amendment $2,178,277 $0
Amendment $2,178,277 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $2,189,617 $0
Amendment $2,189,617 $2,189,617
Amendment $2,189,617 $0
Amendment $2,189,617 $2,189,617
Original award $2,200,637 $0
Show all 15

Subawards

Subrecipient Amount Awarded
Eberhard Karls Universitat Tubingen The retinal specialists at this institution have already identified 29 BEST1 VMD patients who can be enrolled into this study. $77,830
Fondation Voir Et Entendre Fondation Voir et Entendre Drs. Audo & Zeitz have identified 70 Best1 VMD patients and are still screening a large cohort of potential patients. They will… $126,400

Quick answers

Who received award R24EY028758?

R24EY028758 was awarded to The Trustees Of Columbia University In The City Of New York by National Eye Institute (National Institutes of Health) on June 1, 2020.

How much is award R24EY028758 worth?

$21,848,123 has been obligated on R24EY028758: $17,468,889 in federal funding and $4,379,234 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award